SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-18-026641
Filing Date
2018-04-25
Accepted
2018-04-25 16:38:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8851
  Complete submission text file 0001104659-18-026641.txt   9840
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations